Real-world assessment of adherence to inclisiran dosing schedule and LDL-C reduction in patients with hypercholesterolemia in Austria.

Pätzold D, Vonbank A, Clodi M, Sourij H, Hubner D, Ebenbichler C, Fagan A, Farries G, Hofstätter E, Nitzlader M, Gangl D, Adlbrecht C

Open source

DOI
10.1016/j.jacl.2026.07.025
Published
2026 Sep
Container
Journal of clinical lipidology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacl.2026.07.025,
  title = {Real-world assessment of adherence to inclisiran dosing schedule and LDL-C reduction in patients with hypercholesterolemia in Austria.},
  author = {Pätzold D and Vonbank A and Clodi M and Sourij H and Hubner D and Ebenbichler C and Fagan A and Farries G and Hofstätter E and Nitzlader M and Gangl D and Adlbrecht C},
  year = {2026},
  journal = {Journal of clinical lipidology},
  doi = {10.1016/j.jacl.2026.07.025},
  url = {https://doi.org/10.1016/j.jacl.2026.07.025}
}

RIS

TY  - JOUR
TI  - Real-world assessment of adherence to inclisiran dosing schedule and LDL-C reduction in patients with hypercholesterolemia in Austria.
AU  - Pätzold D
AU  - Vonbank A
AU  - Clodi M
AU  - Sourij H
AU  - Hubner D
AU  - Ebenbichler C
AU  - Fagan A
AU  - Farries G
AU  - Hofstätter E
AU  - Nitzlader M
AU  - Gangl D
AU  - Adlbrecht C
PY  - 2026
JO  - Journal of clinical lipidology
DO  - 10.1016/j.jacl.2026.07.025
UR  - https://doi.org/10.1016/j.jacl.2026.07.025
ER  - 

APA

D, P., A, V., M, C., H, S., D, H., C, E., A, F., G, F., E, H., M, N., D, G., & C, A. (2026). Real-world assessment of adherence to inclisiran dosing schedule and LDL-C reduction in patients with hypercholesterolemia in Austria.. Journal of clinical lipidology. https://doi.org/10.1016/j.jacl.2026.07.025

Source records